Sophisticated AI analysis reveals efficacy of neuroprotective drug for severe stroke
New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective...
Continue reading
This website may not work correctly in Internet Explorer. We recommend switching to a more secure modern web browser such as Microsoft Edge which is already installed on your computer.
Perron Institute’s Media Centre displays media statements and is the central point of contact for journalists and media outlets seeking expert comments, latest research developments and other information.
All media enquiries should be directed to Perron Institute’s Communications Manager Tennille Kroemer on +61 426 044 223 or tennille.kroemer@perron.uwa.edu.au.
This contact information is for media outlets, publications, journalists and producers only. For all other enquiries, visit the Perron Institute contact page.
New data from AI-driven re-analysis of the Phase 2 clinical trial results by Argenica Therapeutics has confirmed that the neuroprotective...
With deep respect and gratitude, the Perron Institute acknowledges the death of Emeritus Professor Bryant Stokes AO, a revered neurosurgeon whose outstanding contributions have had a massive impact on medical...
Building community capacity in end-of-life care and dispelling misconceptions are themes of a recently published editorial in the journal Palliative Care and Social Practice. Co-author...
The Member of the Order of Australia (AM) honour awarded to Professor Minghao Zheng AM for advancement of regenerative medicine...
Developing a personalised prescribing model to improve treatment for depression and anxiety is the aim of a leading-edge mental health...
Western Australia’s Perron Institute has recently appointed two non-Executive Directors, each with an impressive record of achievement in their fields of expertise. Paul Anderson has 25 years’ experience in...
Research on genetic causes of dystonia in Australian families affected by this severely disabling neurological movement disorder has received support under the 2025-26 WA Government’s Future...
The rapidly evolving field of precision medicine and how it is reshaping the understanding and treatment of motor neurone disease (MND) is explored in a recent review led by researchers in Western Australia as...
The protocol of an Australian-first pilot study based at the Perron Institute in Western Australia which explores the efficacy of personalised antidepressants in young people with major depressive disorder (MDD) has been published. ...
UPDATE – Course change won’t stop Team Andy’s epic Telethon swim challenge! The third annual Team Andy’s Swim for Telethon...
For the sixth consecutive year, golfing enthusiasts and novice players converged on Wembley Golf Course in October for a thrilling...
Statistics show that young Australians under 25 are at a high risk of mental health disorders, with around one in...
Stay up to date with our latest news and announcements.